peptide sciences glp 1 Semaglutide Companies seek a second obesity

The short answer is: likely yes, with appropriate medical supervision

Originally created to help people living with type 2 diabetes, drugs like Zepbound and Wegovy have skyrocketed in popularity for their powerful effects on weight loss

[DOI] [PMC free article] [PubMed] [Google Scholar] 45.Wilson DM, et al

Researchers at the University of Southern California and others examined the medical records of people taking GLP-1s for their type 2 diabetes

G., Contreras, V., Menini, T., & Gugliucci, A

Patients may experience side effects such as gastrointestinal discomfort, and certain populations, such as those with pancreatitis or severe gastrointestinal disorders, may not be suitable candidates